BMO Capital analyst Keith Bachman maintains Splunk (NASDAQ:SPLK) with a Outperform and raises the price target from $144 to $148.
Piper Sandler Maintains Overweight on KORU Medical Systems, Raises Price Target to $4.5
Piper Sandler analyst Jason Bednar maintains KORU Medical Systems (NASDAQ:KRMD) with a Overweight and raises the price target from $3.5 to $4.5.